177 related articles for article (PubMed ID: 3365649)
1. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
Teicher BA; Holden SA; Crawford JM
Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649
[TBL] [Abstract][Full Text] [Related]
2. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
Teicher BA; Herman TS; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
[TBL] [Abstract][Full Text] [Related]
3. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
4. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
Kim GE; Song CW
Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Teicher BA; Bernal SD; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
8. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
Teicher BA; Holden SA; Cathcart KN; Herman TS
J Natl Cancer Inst; 1988 Jun; 80(8):599-603. PubMed ID: 2453675
[TBL] [Abstract][Full Text] [Related]
9. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
10. Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents.
Teicher BA; McIntosh-Lowe NL; Rose CM
Biomater Artif Cells Artif Organs; 1988; 16(1-3):533-46. PubMed ID: 2460166
[TBL] [Abstract][Full Text] [Related]
11. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
12. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
13. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
Holden SA; Herman TS; Teicher BA
Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
[TBL] [Abstract][Full Text] [Related]
14. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
15. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
Teicher BA; Holden SA; Rose CM
Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Teicher BA; Herman TS; Rose CM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
[TBL] [Abstract][Full Text] [Related]
17. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
19. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
20. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
